Skip to main content
Signal8

Glickman Mark A

SEC insider (Form 3/4/5 filer). CIK 0001441461. Director at BioStem Technologies, Inc. (BSEM) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 27, 2026. Located in POMPANO BEACH, FL.

Companies Glickman Mark A has filed insider reports for

  • BioStem Technologies, Inc. (BSEM): Director
  • MetaVia Inc. (MTVA): Director
Glickman Mark A profile photo

Glickman Mark A

CIK: 0001441461

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (33.3%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

BioStem Technologies, Inc. logo
BSEM

BioStem Technologies, Inc.

Director
MetaVia Inc. logo
MTVA

MetaVia Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • BioStem Technologies, Inc. logo
    BSEM

    BioStem Technologies, Inc.

    Aug 27, 2026
    Exercise
    Direct
    7.7K shares-
  • MetaVia Inc. logo
    MTVA

    MetaVia Inc.

    Jun 8, 2026
    Award
    Direct
    17.2K shares-
  • MetaVia Inc. logo
    MTVA

    MetaVia Inc.

    Jun 30, 2025
    Award
    Direct
    28.1K shares-

1-3 of 3